Biotechnology

Report Name Published
Real-time PCR And Digital PCR Market

The global real time PCR (qPCR) and digital PCR (dPCR) market is expected to reach USD 6.4 billion by 2022, according to a new report by, Key Market Insights. Implementation of Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) and Real-time PCR Data Markup Language (RDML) guidelines that ensure high-quality results is estimated to provide the market with high growth opportunities In addition, increasing number of research & forensic laboratories and CROs is a key factor responsible for market growth. Laboratories and CROs use qPCR and dPCR techniques for gene-based, protein-based, and various other research applications owing to its high accuracy and sensitivity. Increasing preference of PCR techniques in prenatal genetic testing and its associated advantages in prenatal genetic testing such as lack of need for reference standards, low cycle times, and reproducible results are some of the drivers expected to propel growth. Furthermore, major players are in the process of acquiring companies manufacturing diagnostic devices for the development of technologically advanced qPCR and dPCR products. For instance, Bio-Rad laboratories acquired RainDance Technologies to strengthen their position in the area of digital PCR.

2017
Biobanking Market

Biobanking - Global Market Outlook (2017-2022) According to Stratistics MRC, the Global Biobanking Market is expected to grow at a CAGR of 9.5% during the forecast period. Factors such as occurrence of chronic diseases, increase in aging population and decrease in research expenses are fueling the market growth. By sample type, human tissues segment is largest market accounting for almost 55% of the total market share during the forecast period. The unavailability of proper animal models for some neurological and psychiatric diseases is a significant factor in the growing preference for human tissue. By product type, equipment segment commanded the largest market share during the forecast period. By geography, North America and Europe commanded the largest market share attendance of large players that are domiciled out of these nations. Some of the key players in Biobanking market include Thermo Fisher Scientific, DNA Genotek, BioStorage Technologies, Askion GmBH, LVL Technologies, Cryo Bio System, BioRep SRL, Seralab, Tissue Solutions, SOL Group, Micronic, Brooks Life Science Systems, Fluidx, CryoXtract and Beckman Coulter. Applications Covered: Population Biobanks Virtual Biobanks Tissue Biobanks Product Types Covered: Consumables Equipment Sample Types Covered: Stem Cells Bio-fluids Human Tissues Deoxyribonucleic acid (DNA) Ribonucleic acid (RNA) Other Sample Types Regions Covered: North America US Canada Mexico Europe Germany France Italy UK Spain Rest of Europe Asia Pacific Japan China India Australia New Zealand Rest of Asia Pacific Rest of the World Middle East Brazil Argentina South Africa Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements

2017
Global Microencapsulation Technology Market Size, Status and Forecast 2022

This report studies the global Microencapsulation Technology market, analyzes and researches the Microencapsulation Technology development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like BASF SE Syngenta Crop Protection AG Royal (Koninklijke) Frieslandcampina N.V. Koninklijke DSM N.V. Givaudan SA Symrise AG International Flavors & Fragrances Inc. Lycored Corp. Koehler Innovative Solutions Balchem Corporation Encapsys LLC. Arcade Beauty Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Microencapsulation Technology can be split into Spray Technologies Emulsion Technologies Dripping Others Market segment by Application, Microencapsulation Technology can be split into Pharmaceutical & Healthcare Products Food & Beverages Household & Personal Care Products Agrochemicals Construction Materials Textiles Others If you have any special requirements, please let us know and we will offer you the report as you want. Information and communications technology, commonly abbreviated as ICT, is a relatively recent extension of the IT domain. It incorporates a greater level of focus on the unification of communications across various roles and platforms, while promoting the integration of different technologies. These can include software that are meant for individual, commercial, or enterprise usage, as well as several types of middleware, A/V systems, and storage data storage components. Most entities of the ICT sector are aware and accepting of the fact that the rate of change of technologies in the ICT sector can be extremely fast. This implies a much more dynamic approach that players in this industry should be taking. The primary goal of most entities offering ICT services and technologies is to cut down the overall expenses of their clients when it comes to communications, while creating innovations that allow them to improve the said communication means. The global industry for ICT is expected to continue growing at a very optimistic rate for the time being, due to the important role that it plays in the overall development of any economy. The segmentations of the Global microencapsulation technology market size status and forecast 2022 can be made on the basis of its key categories that best describe the functioning of individual aspects of the market. This segmented analysis allows users of this report to gauge their standing in each category. Larger players who are likely to be associated with multiple categories can visualize their trajectories over the coming years based on the decisions they have made so far, and change their course accordingly. Smaller players can formulate better strategies of growth in individual segments or to plan their foray into additional segments based on the level of success that they can gain from them. The report also encourages users to take a step in the right direction by portraying the strengths and weaknesses, drivers and restraints, and overall opportunities of each given segment. The geographical review of the Global microencapsulation technology market size status and forecast 2022 will conclusively allow regional players to assert their stake in the market in the right manner, while also allowing globally inclined players to assess the rate at which their regional assets may expand. For each key region, the report provides a statistical chart of what the market looked like recently and what it is expected to become over the given forecast period. Armed with this knowledge, a player in the market of any size can create a more successful prospective for themselves over the coming years. The Global microencapsulation technology market size status and forecast 2022 can also be clarified on the basis of its competitive landscape, an all-inclusive analysis of the player activities and profiles in the market so far. The report provides specially detailed information on the leading players of the market, which includes naming their regions of prominence, statistical data that as released on their financial statuses, their current areas of expertise, and their projected actions for the coming years. The overall intention of providing this analysis for the market is to equip players with foresight based on the bigger influencers of the market’s growth patterns.

2017
2017-2022 Microbiology & Bacterial Culture for Industrial Testing Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

This report studies the Microbiology & Bacterial Culture for Industrial Testing market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Microbiology & Bacterial Culture for Industrial Testing market by product type and applications/end industries. The global Microbiology & Bacterial Culture for Industrial Testing market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Microbiology & Bacterial Culture for Industrial Testing. United States plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of XX. Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Microbiology & Bacterial Culture for Industrial Testing in these regions, from 2012 to 2022 (forecast), covering United States North America Europe Asia-Pacific South America Middle East and Africa The major players in global and United States Microbiology & Bacterial Culture for Industrial Testing market, including Abbott Laboratories, ATCC, Becton, Dickinson and Company, BioMieux SA, Bio-Rad Laboratories, Inc., Bruker Corporation, Cepheid Inc., Danaher Corporation, EIKEN CHEMICAL CO., LTD., Hardy Diagnostics, HiMedia Laboratories, Merck KGaA, NEOGEN CORPORATION, Thermo Fisher Scientific, Inc., Titan Biotech Limited. The On the basis of product, the Microbiology & Bacterial Culture for Industrial Testing market is primarily split into Sera Reagents Media On the basis on the end users/applications, this report covers Bioenergy & Agricultural Research Food Animal Feed Water Testing Other Application A massive portion of the overall impetus that players and markets associated with biotechnology are receiving, comes from the rapidly increasing government support. Developed economies are especially ahead of the game in terms of research and development, as well as the incorporation of ready products into the commercial markets. However, it should be noted that the average time to market for a standard biotechnology product is exceedingly higher than conventional medical products. Despite this, players are becoming ever ready to tackle the more promising fields in biotechnology, namely stem cell technology, nanotechnology, and genetic cloning. This field is poised to be an inseparable part of the healthcare industry, and is in need of heavy efforts on the research and development side. The 2017 2022 microbiology and bacterial culture for industrial testing report on global and united states market status and forecast by players types and applications is a very different market loaded with exceptional competitors and very specific customer and end user appeals. The improvement of innovations is additionally in high demand, with the developed economies demonstrating a more prominent consideration in the advancement of cutting edge advances than the developing economies. The report considers every such element while surveying the upcoming expected openings for players in the market over the coming years. It therefore converts the data presented into a matter of point of view, and offers the most ideal one for the market as far as getting favored by the key drivers and patterns influencing the market is concerned, while evading the hindrances that could prevent the advance of the players. The establishment for this investigation is made by getting the readers of this report familiar with the basic syntax of the market as it is important to completely comprehend its progression that the said entities are expected to promote themselves on. The regional examination of the 2017 2022 microbiology and bacterial culture for industrial testing report on global and united states market status and forecast by players types and applications can be depicted as a widely inclusive survey of the key locations, from the points of view of these locations as specified through their existing player base and the general end user reports for them. This is a doubly useful approach in market examination for the regional companies, as it helps them see precisely what their field of operation needs, as far as their end users are concerned. Moreover, investors will be able to figure out which organization they can pay special attention to when attempting to extend their investments profiles. Additionally, the level of detail with which every segment and region is depicted can build this report up to be a convenient guide for them with regards to enhancing their place in a particular region or country, or with regards to entering new market fruitfully over the coming years. The competitive analysis presented in the report on the 2017 2022 microbiology and bacterial culture for industrial testing report on global and united states market status and forecast by players types and applications can be an imperative device in the overall arsenal that a market player possesses. A careful learning and understanding of the competitive profiles and the contentions between players is a crucial bit of data needed by all market players, and it is the thing that this report gives to every client. The level of customization for every player takes into consideration an extraordinary standpoint for them, taking into account significantly more noteworthy data.

2017
Europe Bioinformatics Market Report 2017

Notes: Sales, means the sales volume of Bioinformatics Revenue, means the sales value of Bioinformatics This report studies sales (consumption) of Bioinformatics in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering DNAnexus, Inc.? ID Business Solutions Ltd.? Perkinelmer, Inc.? Waters Corporation Illumina, Inc.? Thermo Fisher Scientific Inc.? Qiagen N.V.? Agilent Technologies? Applied Biological Materials (ABM)? Biomax Informatics Ag? Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Bioinformatics in these countries, from 2011 to 2021 (forecast), like Germany France UK Russia Italy Spain Benelux Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into Knowledge Management Tools? Bioinformatics Platforms Bioinformatics Services? Split by application, this report focuses on sales, market share and growth rate of Bioinformatics in each application, can be divided into Genomics? Chemoinformatics and Drug Design? Proteomics? Transcriptomics? Metabolomics? Molecular Phylogenetics? Others

2017
Global Regenerative Artificial Skin Market

In this report, the global Regenerative Artificial Skin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Regenerative Artificial Skin in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Global Regenerative Artificial Skin market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Integra Life Sciences Mylan Johnson & Johnson Smith & Nephew Mallinckrodt ... On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Temporary Skin Material Permanent Skin Material Composite Skin Material On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Regenerative Artificial Skin for each application, including Hospitals Clinics Burn Care Centers If you have any special requirements, please let us know and we will offer you the report as you want.

2017
Global Agrigenomics Market Research Report 2017

Summary This report studies Agrigenomics in Global market, especially in North America, Europe, South America, Asia Pacific, Rest of the World and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Agrigenome Illumina Thermo Fisher Scientific Inc NuGEN Technologies Edico Genome LGC Limited Eurofins USA Affymetrix Agena Bioscience ArrayGen Technologies SciGenom UD-GenoMed Medical Genomic Technologies Ltd CEN4GEN Institute Genotypic Technology Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Agrigenomics in these regions, from 2011 to 2021 (forecast), like North America South America Europe Asia Pacific Rest of the World Split by Service Types, with production, revenue, price, market share and growth rate of each type, can be divided into DNA Sequencing RNA Sequencing DNA Methylation Analysis Chromatin Analysis Split by applications, this report focuses on consumption, market share and growth rate of Agrigenomics in each application, can be divided into Livestock Crops Ovine Fowl Fish Others

2017
Artificial Insemination - Global Market Outlook (2016-2022)

According to Stratistics MRC, the Artificial Insemination Market is estimated at $XX million in 2015 and is expected to reach $XX million by 2022 growing at a CAGR of XX% from 2015 to 2022. Changing lifestyle and growing focus of modern women regarding Planned Parenthood due to uninterrupted full time career are some of the key factors anticipated to drive the growth of the global artificial insemination market. Moreover, factors such as cost efficiency in comparison to other fertilization procedures and rising cases of male infertility are the other factors that could boost the market. However, the market is facing some of challenges which include safety issues, ethical concerns, and high risk of transmission of sexual transmitted diseases. Amongst end users, home based segment is expected to grow at a high CAGR after hospital and fertility centers due to availability of various easy to use kits in the market. Asia Pacific holds the largest share in the global market and is expected to grow which can be attributed to increasing disposable income and awareness amongst the population. Some of the key players in this market include Bescot Healthcare, Hi-Tech Solutions, Church & Dwight Co. Inc., Conceivex Inc, Rinovum Women's Health LLC (US), TenderNeeds Fertility, Pride Angel, Clearblue, Insemination Supplies, LLC, The Stork Ib2C, Inc., Kate & Duck and Boots Pharmaceuticals. Techniques Covered: • Intracervical Insemination (ICI) • Intratubal Insemination (ITI) • Intrauterine Insemination (IUI) • Intravaginal Insemination (IVI) • Other Techniques Types Covered: • Artificial Insemination With Homologous (AIH) • Donor Artificial Insemination (AID) Type of Products Covered: • Home Conception Devices o Zestica Conception Kit o Stork Conception Device o Boots Conception Kit o Conceivex Conception Kit o Others (Pre-Launched) • Insemination Kits o Deluxe Insemination Kit o Large Insemination Kit o Deluxe Kit with Ovulation Cassette o Basic Artificial Insemination Kit o Large Kit with Ovulation Cassette o Basic Kit with Ovulation Cassette o Other Insemination Kits • Accessories o Collection cup o Tubes o Ovulation and Pregnancy Test Kits o Needleless syringe o Cervical Cap o Other Accessories • Ultimate Insemination Kit • Essential Insemination Kit • Other Disposables End Users Covered: • Clinics • Hospitals • Home Based • Fertility Centre • Other End Users Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements

2017
Asia-Pacific Biotechnology Separation Systems Market Report 2017

Summary In this report, the Asia-Pacific Biotechnology Separation Systems market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Biotechnology Separation Systems for these regions, from 2012 to 2022 (forecast), including China Japan South Korea Taiwan India Southeast Asia Australia Asia-Pacific Biotechnology Separation Systems market competition by top manufacturers/players, with Biotechnology Separation Systems sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Danaher Thermo Fisher Scientific BD Merck GE Healthcare Agilent Sysmex Alfa Wassermann Shimadzu Sartorius Stedim Biotech Illumina Waters Novasep 3M Purification Affymetrix Bio-Rad Laboratories Alfa Laval PerkinElmer Repligen Hitachi Koki On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into Membrane Filtration Chromatography Centrifuge Electrophoresis Flow Cytometry Others On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Biotechnology Separation Systems for each application, includin Commercial Scientific Research If you have any special requirements, please let us know and we will offer you the report as you want.

2017
2017-2022 Global and Japan Marine Biotechnology Market Analysis Report

Summary The global Marine Biotechnology market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022. Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%. This report, with focus on top players in the global and Japan, studies the Marine Biotechnology market's development status and future trend in the global and Japan. It splits Marine Biotechnology market by type and by applications to fully and deeply research and reveal market profile and prospect. The major players include Marinova NEB BiotechMarine GlycoMar Marine Biotech Nofima Sams Aquapharm Geographically, this report splits the Global market into the following regions: Asia Pacific Japan Tokyo Yokohama Osaka Nagoya Others China Korea India Others Europe France Germany United Kingdom Italy Russia Others North America United States Canada Latin America Brazil Mexico Others Southeast Asia Singapore Malaysia Vietnam Myanmar Thailand Indonesia Philippines Others Middle East & Africa Saudi Arabia Iran UAE Turkey Israel Egypt South Africa Others On the basis of product, the Marine Biotechnology market is primarily split into By Research Object Marine Animal Technology Marine Plant Technology By Biotechnology Genetic Engineering Cell Engineering Fermentation Engineering Key Applications Cosmetics Pharmaceuticals Fine Chemical Nutritional Supplements

2017
Global Chiropractic Software Market Size, Status and Forecast 2022

This report studies the global Chiropractic Software market, analyzes and researches the Chiropractic Software development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like AdvancedMD MacPractice Nuesoft Technologies OfficeAlly Practice Fusion Addison Health Systems Atlas Chiropractic System ChiroPulse ChiroSpring ChiroTouch ClinicPro.com CloudChiro CollaborateMD CompuGroup Medical drchrono E-Z BIS Forte Holdings Genesis Chiropractic Software InPhase Technologies iSALUS Healthcare Life Systems Software Medicfusion Meditab MPN Software Systems MRX Solutions TotalMD WonderDoc Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Chiropractic Software can be split into Cloud-based Chiropractic Software Web-based Chiropractic Software Market segment by Application, Chiropractic Software can be split into Hospitals Research Institutes Others If you have any special requirements, please let us know and we will offer you the report as you want.

2017
Global Marine Biotechnology Market Professional Survey Report 2017

Summary This report studies Marine Biotechnology in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Marinova NEB BiotechMarine GlycoMar Marine Biotech Nofima Sams Aquapharm ... On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Marine Animal Technology Marine Plant Technology By Application, the market can be split into Cosmetics Pharmaceuticals Fine Chemical Nutritional Supplements By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India If you have any special requirements, please let us know and we will offer you the report as you want.

2017
Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth

Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth Summary Immunology is a therapy area characterized by disorders of the immune system, specifically an aberrant autoimmune response against healthy tissues in the body, leading to chronic or acute inflammation. Depending on the specific site affected, this can lead to various types of chronic pain and mobility loss, and have a negative impact on quality of life. A number of therapies have been approved for immunological disorders, including the largely genericized disease-modifying anti-rheumatic drug (DMARD) class of small molecule drugs. However, as these therapies often fail to elicit an adequate long-term response, a large second-line therapy segment has emerged in these markets, beginning with the approval of Remicade (infliximab) and Enbrel (etanercept) in 1998. There is currently no cure for immunological disorders due to the highly complex nature of the immune system and the fact that many components of the pathophysiological states of these diseases have roles in the healthy immune system. Autoimmune disorders are currently incurable, and treatment is aimed at managing the disease, in order to reduce the severity of its symptoms and lower the risk of associated co-morbidities. Cytokines and their receptors, such as Tumor Necrosis Factor-? and Interleukin-6 are the most effective and most common therapies used in immunology. This class of compounds has been the most commercially successful in the past decade, particularly in the RA market, with many clinical trials underway across various immunological indications. The market for immunological disorders is largely accounted for by premium products, with only a relatively small revenue share accounted for by generics and biosimilars. Inflectra, a biosimilar of Remicade was recently approved by the FDA in 2016. However, the gradual uptake of biosimilars such as Inflectra is not expected to act as a strong growth driver for the biosimilar segment within the forecast period. This therefore means existing products such as Remicade are expected to maintain high revenues during the forecast period Although there is a high degree of failure and uncertainty in R&D of immunological drugs, there are 2,054 drugs in active development in the immunology pipeline. In the long-term, this is expected to drive growth in this market in spite of the anticipated approval of biosimilars for key blockbuster drugs and resultant erosion of revenues. Cytokines and their receptors account for the largest single segment of each of the pipelines which make up the largest individual class. The report focuses on four key indications within immunology: Rheumatoid arthritis, Systemic lupus erythematosus (SLE), Psoriasis and Inflammatory bowel disease (The two major types of Inflammatory bowel disease covered in this report are Ulcerative colitis and Crohn’s disease). With no curative therapies available, symptomatic medications prescribed off-label are an important part of the treatment paradigm, especially in SLE, increasing the need for extensive R&D within this area. Scope - Global revenues for the immunology market are forecast to grow at a compound annual growth rate of 3.63%, from $57.7 billion in 2015 to $74.1 billion in 2022. - Which drugs will achieve blockbuster status and how will the key player companies perform during the forecast period? - The immunological disorders pipeline is large and diverse, and contains 2,054 products. How does the composition of the pipeline compare with that of the existing market? - What molecular targets and molecule types are most commonly being trialed in pipeline products in the key indications? - Which products will contribute to market growth most significantly, and which will achieve blockbuster status? - Will the current market leaders retain their dominance over the forecast period, and how is their revenue share of the immunology market set to change? Reasons to buy - Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment options available at each stage of diagnosis - Visualize the composition of the immunology market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players - Analyze the immunological disorders pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications - Understand the growth in patient epidemiology and market revenues for the immunology market, globally and across the key players and product types - Stratify the market in terms of the split between generic and premium products, and assess the role of these product types in the treatment of the various immunological disorders. - Identify commercial opportunities in the immunology deals landscape by analyzing trends in licensing and co-development deals

2017
Top Trends in Toiletries and Hygiene 2017: Exploring the oral hygiene, personal hygiene, feminine hygiene and incontinence categories

Top Trends in Toiletries and Hygiene 2017: Exploring the oral hygiene, personal hygiene, feminine hygiene and incontinence categories Summary "Top Trends in Toiletries and Hygiene 2017" is part of GlobalData's Top Trends series. It examines the key consumer behaviors that are shaping preferences within this space, and subsequently how this is translating into innovation and future opportunities. The toiletries and hygiene sector represents a highly dynamic space for growth as consumers’ quest for efficacy and experimentation continues and evolves. Overarching themes continue to be challenging efficiency without affecting quality, the influence of foreign cultures on skincare regimens, and clean labeling. Scope - Today's consumers lead busy lives with seemingly endless tasks, be they for work or for leisure. This is creating an opportunity for products with energizing properties outside of food and drink. - Adding new approaches and steps to existing regimes, perhaps influenced by other cultures, can create important opportunities for growth by providing unique solutions and capitalizing on interest in such innovation. - Consumers associate personal wellbeing with their appearance, and are actively look for products that are "cleaner," safer, and more authentic. - Innovation-hungry consumers will look for products that can offer novel or fun experiences, or that have attributes that can deliver on functionality as well as product experience. - Consumers want products that can help them save time. This means they are constantly seeking products that can do just this, without compromising on quality. Reasons to buy - Identify how brands can innovate to engage consumers as well as showcasing best-in-class innovation examples throughout. - Learn what consumer behavior is driving innovation using GlobalData's latest consumer research. - Access valuable strategic take-outs to help direct future decision-making and inform new product development.

2017
Bone Cancer Global Clinical Trials Review, H1, 2017

Bone Cancer Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Bone Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Bone Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bone Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

2017
Blood Coagulation Global Clinical Trials Review, H1, 2017

Blood Coagulation Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Blood Coagulation Global Clinical Trials Review, H1, 2017" provides an overview of Blood Coagulation clinical trials scenario. This report provides top line data relating to the clinical trials on Blood Coagulation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

2017
Blepharospasm Global Clinical Trials Review, H1, 2017

Blepharospasm Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Blepharospasm Global Clinical Trials Review, H1, 2017" provides an overview of Blepharospasm clinical trials scenario. This report provides top line data relating to the clinical trials on Blepharospasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

2017
Blepharitis Global Clinical Trials Review, H1, 2017

Blepharitis Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Blepharitis Global Clinical Trials Review, H1, 2017" provides an overview of Blepharitis clinical trials scenario. This report provides top line data relating to the clinical trials on Blepharitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

2017
Bladder Pain Global Clinical Trials Review, H1, 2017

Bladder Pain Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Bladder Pain Global Clinical Trials Review, H1, 2017" provides an overview of Bladder Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

2017
Bladder Cancer Global Clinical Trials Review, H1, 2017

Bladder Cancer Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Bladder Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Bladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

2017